The overexpression of IGF2BP2 might be driven by multiple mechanisms, including the loss of tumour-suppressive miRNAs, gene amplification and upregulation mediated by the lncRNA LINC00901 [154,156]. The gene discussed is IGF2BP2; the disease is neoplasm.